Biggest public healthcare companies
Ranked nationally by total revenue reported in each healthcare company's most recent annual SEC filing (10-K). Figures are factual reference only and are not investment advice.
| # | Company | Revenue (dated) | Industry |
|---|---|---|---|
| 1 | UnitedHealth Group | $448B (FY 2025) | finance, healthcare |
| 2 | Cardinal Health | $223B (FY 2025) | healthcare |
| 3 | Elevance Health | $199B (FY 2025) | finance, healthcare |
| 4 | Centene Corporation | $175B (FY 2025) | healthcare |
| 5 | Johnson & Johnson | $94B (FY 2025) | technology, healthcare |
| 6 | Procter & Gamble | $84B (FY 2025) | healthcare, consumer goods |
| 7 | Eli Lilly and Company | $65B (FY 2025) | healthcare |
| 8 | Abbvie | $61B (FY 2025) | technology, healthcare |
| 9 | Pfizer | $51B (FY 2023) | healthcare |
| 10 | Bristol-Myers Squibb | $48B (FY 2025) | healthcare |
| 11 | Thermo Fisher Scientific | $45B (FY 2025) | technology, healthcare |
| 12 | Abbott Laboratories | $44B (FY 2025) | technology, healthcare |
| 13 | Honeywell | $37B (FY 2025) | healthcare, retail, manufacturing, aerospace defense |
| 14 | Amgen | $37B (FY 2025) | healthcare |
| 15 | Medtronic | $36B (FY 2026) | technology, healthcare |
| 16 | Gilead Sciences | $29B (FY 2025) | healthcare |
| 17 | Stryker Corporation | $25B (FY 2025) | technology, healthcare |
| 18 | Tenet Healthcare | $21B (FY 2025) | healthcare |
| 19 | GE Healthcare | $21B (FY 2025) | technology, healthcare, manufacturing |
| 20 | MGM Resorts International | $18B (FY 2025) | healthcare |
| 21 | IQVIA | $16B (FY 2025) | healthcare |
| 22 | Regeneron Pharmaceuticals | $14B (FY 2025) | healthcare |
| 23 | LabCorp | $14B (FY 2025) | healthcare |
| 24 | DaVita Inc. | $14B (FY 2025) | healthcare |
| 25 | Community Health Systems | $12B (FY 2025) | healthcare |
| 26 | Baxter | $11B (FY 2025) | healthcare |
| 27 | Biogen | $9.9B (FY 2025) | healthcare |
| 28 | Zimmer Biomet | $8.2B (FY 2025) | healthcare |
| 29 | Ingredion | $7.2B (FY 2025) | healthcare, food and beverage |
| 30 | Encompass Health | $5.9B (FY 2025) | healthcare |
| 31 | Select Medical Corporation | $5.5B (FY 2025) | healthcare |
| 32 | Incyte | $5.1B (FY 2025) | healthcare |
| 33 | Bausch & Lomb | $5.1B (FY 2025) | healthcare |
| 34 | Perrigo | $4.3B (FY 2025) | healthcare |
| 35 | Align Technology | $4.0B (FY 2025) | healthcare |
| 36 | BioMarin Pharmaceutical | $3.2B (FY 2025) | technology, healthcare |
| 37 | Neurocrine Biosciences | $2.9B (FY 2025) | technology, healthcare |
| 38 | Teleflex, Inc. | $2.0B (FY 2025) | healthcare |
| 39 | Moderna | $1.9B (FY 2025) | technology, healthcare |
| 40 | Acadia Pharmaceuticals | $1.1B (FY 2025) | healthcare |
| 41 | Myriad Genetics | $825M (FY 2025) | healthcare |
| 42 | Marcus Corporation | $758M (FY 2025) | healthcare |
| 43 | GoHealth | $362M (FY 2025) | healthcare |
| 44 | PetMed Express | $179M (FY 2026) | healthcare |
| 45 | BioCryst Pharmaceuticals | $25M (FY 2017) | healthcare |
Revenue figures come from SEC EDGAR and are factual reference only. This is not investment advice.